Ledger.

Company

Azura

Coverage

Stories naming Azura. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

4 deals

Archangel Ventures - 2022: Year in Review

Archangel Ventures' annual review recounts closing its second fund above $32 million, passing $10 million invested in Australian startups, and portfolio raises by Aerotruth, Bare, Trendspek, Pearler and Vively during 2022.

Archangel Ventures portfolio Sat 21 Jan 2023 AerotruthArchangel VenturesBareVivelyAfterwork VenturesAntler AustraliaAzuraBlackbird VenturesEVPFlying Fox VenturesGiant LeapHeaps NormalJelix VenturesMain Sequence VenturesOIF VenturesPearlerPortageSquare Peg CapitalTen13The IconicTrebleTrendspekUtiliti Ventures

Also Startup Daily·SmartCompany·Startup Daily·Startup Daily·Forbes Australia

2 deals

Brandon Capital Partners launches new Medical Research Commercialisation Fund, seeks NZ institutional

Brandon Capital's Medical Research Commercialisation Fund has launched its fifth vehicle, MRCF5, completing a NZ$224 million first close and targeting NZ$267 million, while recalling earlier portfolio exits of Elastagen, Spinifex and Fibrotech.

Brandon Capital portfolio Wed 1 May 2019 Brandon Capital PartnersAllergan plcAravaxAustralian GovernmentAzuraBaker Heart & Diabetes InstituteCERTA TherapeuticsEBR SystemsElastagen Pty LtdFibrotechFlorey Institute of Neuroscience and Mental HealthGlobal KineticsMedical Research Commercialisation Fund (MRCF)MRCF3MRCF5MRCF BTF (MRCF4)NovartisOncoRes MedicalOspreyPolyactivaQue OncologyShire plcSpinifexVaxxasAustralianSuperCSLHESTAHostplusStatewideSuperDr Chris NaveDuncan Mackintosh

Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Startup Daily

Something wrong? Tell us